Chinese glass packaging maker Linuo Packaging files for HKEX listing
Shandong Linuo Pharmaceutical Packaging, already listed in Shenzhen as Linuo Packaging (301188.SZ), filed on 28 September 2026 for a dual Main Board listing on the Hong Kong Stock Exchange. The borosilicate glass specialist ranks second globally in heat-resistant glass for daily use with a 5.1% share and ninth in China's pharmaceutical glass packaging market. The listing filing coincides with the company's move into glass substrates for semiconductor packaging, where a pilot furnace was ignited in June 2026.
Why this mattersA dual listing would give a top-two global heat-resistant glass maker fresh capital access as it diversifies into semiconductor-grade glass substrates.
- Shandong Linuo Pharmaceutical Packaging (301188.SZ, listed in Shenzhen) filed on 28 September 2026 for a Main Board listing on the Hong Kong Stock Exchange.
- China Merchants Securities International and Lego Financial Group are joint sponsors of the HKEX listing.
- The company ranks second globally in heat-resistant glass for daily use, with a 5.1% market share, and first in China with 9.5% share, per Frost & Sullivan 2025 data.
- It ranks ninth among China pharmaceutical glass packaging suppliers, with a 2.4% market share.
- Products are sold to customers in about 60 countries across the Americas, Asia and Europe.
- A pilot furnace for glass substrates used in semiconductor packaging was ignited in June 2026, with sample provision to industry participants under way.